Market Overview

Bond & Taylor Announce Free GranuFlo® Case Evaluations for Injured Dialysis Patients

Share:

The law firm of Bond & Taylor is announcing free GranuFlo® case evaluations for injured dialysis patients nationwide. The firm is encouraging consumers injured by dialysis to call today to find out what kind of compensation might be available to them.

Irvine, CA (PRWEB) November 02, 2012

The law firm of Bond & Taylor announced today that it was offering free GranuFlo® case evaluations for injured dialysis patients. Following a massive U.S. Food and Drug Administration (FDA) recall of this acid concentrate, thousands of patients and their families have come forward to divulge serious and life altering injuries suffered as the result of dialysis treatment. The law firm of Bond & Taylor is encouraging injured dialysis patients to call today for a free consultation to find out what kind of compensation is available.

On March 29, 2012, the FDA issued a Class 1 recall of two acid concentrates used during dialysis, named GranuFlo® and NaturaLyte®. (Available here: http://www.fda.gov/MedicalDevices/Safety/ListofRecalls/ucm309990.htm) These products were manufactured by Fresenius Medical Care, who also ran the largest network of dialysis care centers across America. In 2010, Fresenius' researchers observed 947 patient heart attacks during dialysis treatment, as noted in the FDA recall. Patients with elevated bicarbonate levels were experiencing overdoses of bicarbonates because of the elevated bicarbonate levels in both GranuFlo® and NaturaLyte®.

Many doctors were unaware of the elevated bicarbonate levels in GranuFlo® and NaturaLyte®. During dialysis treatment, these acid concentrates were administered to reduce acid build up in the blood as toxins such as excess wastes, salts, and toxins were removed from patients' blood. When Fresenius became aware that patients were having serious side effects from these solutions, such as heart attacks, strokes, and death, the company alerted its own network of doctors to the dangers. However, Fresenius' warnings did not reach outside the network until the FDA recall.

In the nearly 125,000 Americans cared for with Fresenius' products, thousands of patients potentially did not receive these lifesaving health warnings. The FDA sought to remedy this with a recall and new drug warnings on packaging. However, thousands of patients have been seriously injured and many are filing suit, claiming their dialysis injuries are the result of a lack of information from Fresenius.

“We are aware that many people are hurting as a result of their dialysis treatment. And we want to hear their stories,” said partner Andrew L. Wright. Bond & Taylor is encouraging injured dialysis patients and their loved ones to contact the firm to discuss potential compensation for these injuries.

###

Extensive product liability experience gives Andrew L. Wright the expertise necessary to handle your defective prescription drug case. With over 20 years of experience as a trial lawyer, Andrew L. Wright is used to standing up for his clients and achieving results.

The law firm of Bond & Taylor has over 30 years of experience fighting zealously on behalf of injured clients and grieving family members who have lost a loved one due to negligence. The firm prides itself on being experts at fighting to achieve the fairness and justice clients deserve. Attorneys at Bond & Taylor are passionate advocates for their clients who seek to treat clients with the compassion and respect they deserve. The attorneys at Bond & Taylor understand clients and their families are suffering and want to fight for the compensation that clients deserve. Cases are accepted nationwide; call the firm of Bond & Taylor for a free confidential consultation at (800) 471-0314. http://bondtaylorinjurylawyers.com/

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/11/prweb10080034.htm

View Comments and Join the Discussion!